Opin vísindi

Fletta eftir efnisorði "Therapy"

Fletta eftir efnisorði "Therapy"

Röðun: Raða: Niðurstöður:

  • Icon
    Integrated Human Evaluation of the Lysophosphatidic Acid Pathway as a Novel Therapeutic Target in Atherosclerosis 
    Aldi, Silvia; Matic, Ljubica Perisic; Hamm, Gregory; van Keulen, Daniëlle; Tempel, Dennie; Holmstrøm, Kim; Szwajda, Agnieszka; Nielsen, Boye Schnack; Emilsson, Valur; Ait-Belkacem, Rima; Lengquist, Mariette; Paulsson-Berne, Gabrielle; Eriksson, Per; Lindeman, Jan H.N.; Gool, Alain J.; Stauber, Jonathan; Hedin, Ulf; Hurt-Camejo, Eva (Elsevier BV, 2018-09-21)
    Variants in thePLPP3gene encoding for lipid phosphatephosphohydrolase 3 have been associated with susceptibilityto atherosclerosis independently of classical risk factors.PLPP3 inactivates lysophosphatidic acid (LPA), a pro-inflam-matory, pro-thrombotic ...
  • Icon
    Management of obstructive sleep apnea in Europe – A 10-year follow-up 
    Fietze, Ingo; Laharnar, Naima; Bargiotas, Panagiotis; Basoglu, Ozen K.; Dogas, Zoran; Drummond, Marta; Fanfulla, Francesco; Gíslason, Þórarinn; Gouveris, Haralampos; Grote, Ludger; Hein, Holger; Jennum, Poul; Joppa, Pavol; van Kralingen, Klaas; Kvamme, John Arthur; Lombardi, Carolina; Ludka, Ondrej; Mallin, Wolfgang; Marrone, Oreste; McNicholas, Walter T.; Mihaicuta, Stefan; Montserrat, Josep; Pillar, Giora; Pataka, Athanasia; Randerath, Winfried; Riha, Renata L.; Roisman, Gabriel; Saaresranta, Tarja; Schiza, Sophia E.; Sliwinski, Pawel; Svaza, Juris; Steiropoulos, Paschalis; Tamisier, Renauld; Testelmans, Dries; Trakada, Georgia; Verbraecken, Johan; Zablockis, Rolandas; Penzel, Thomas (2022-09-01)
    Objective: In 2010, a questionnaire-based study on obstructive sleep apnea (OSA) management in Europe identified differences regarding reimbursement, sleep specialist qualification, and titration procedures. Now, 10 years later, a follow-up study was ...